C. G. Groth

2.5k total citations
78 papers, 1.8k citations indexed

About

C. G. Groth is a scholar working on Surgery, Transplantation and Genetics. According to data from OpenAlex, C. G. Groth has authored 78 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Surgery, 38 papers in Transplantation and 17 papers in Genetics. Recurrent topics in C. G. Groth's work include Renal Transplantation Outcomes and Treatments (38 papers), Pancreatic function and diabetes (27 papers) and Organ Transplantation Techniques and Outcomes (25 papers). C. G. Groth is often cited by papers focused on Renal Transplantation Outcomes and Treatments (38 papers), Pancreatic function and diabetes (27 papers) and Organ Transplantation Techniques and Outcomes (25 papers). C. G. Groth collaborates with scholars based in Sweden, United Kingdom and Germany. C. G. Groth's co-authors include Bo‐Göran Ericzon, B. Gunnar Wallin, Andrew W. Seymour, Oluf Andersen, Philip N. Hawkins, Mark B. Pepys, G Lundgren, Lars Steen, Sylvia Richardson and Ole B. Suhr and has published in prestigious journals such as The Lancet, Diabetes and The Journal of Urology.

In The Last Decade

C. G. Groth

77 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C. G. Groth Sweden	22	775	593	553	261	241	78	1.8k
Walter Mark Austria	24	1.1k 1.4×	619 1.0×	358 0.6×	234 0.9×	153 0.6×	64	1.9k
Lars Wennberg Sweden	24	890 1.1×	507 0.9×	273 0.5×	116 0.4×	327 1.4×	97	1.8k
Regina Verani United States	22	301 0.4×	319 0.5×	341 0.6×	91 0.3×	169 0.7×	56	1.6k
C. G. Groth Sweden	20	1.4k 1.8×	360 0.6×	241 0.4×	78 0.3×	616 2.6×	66	2.0k
A Piazza Italy	17	248 0.3×	317 0.5×	314 0.6×	111 0.4×	93 0.4×	70	1.0k
Raymond J. Tesi United States	23	852 1.1×	864 1.5×	184 0.3×	190 0.7×	104 0.4×	58	1.9k
Khazal Paradis Canada	23	1.2k 1.5×	152 0.3×	334 0.6×	328 1.3×	499 2.1×	59	2.1k
J.P. Duong Van Huyen France	20	749 1.0×	807 1.4×	314 0.6×	238 0.9×	44 0.2×	33	1.7k
Arturo P. Saavedra United States	14	227 0.3×	230 0.4×	212 0.4×	171 0.7×	139 0.6×	40	1.2k
Joseph A. Scarola United States	9	610 0.8×	929 1.6×	162 0.3×	241 0.9×	27 0.1×	12	1.6k

Countries citing papers authored by C. G. Groth

Since Specialization

Citations

This map shows the geographic impact of C. G. Groth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. G. Groth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. G. Groth more than expected).

Fields of papers citing papers by C. G. Groth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. G. Groth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. G. Groth. The network helps show where C. G. Groth may publish in the future.

Co-authorship network of co-authors of C. G. Groth

This figure shows the co-authorship network connecting the top 25 collaborators of C. G. Groth. A scholar is included among the top collaborators of C. G. Groth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. G. Groth. C. G. Groth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Charpentier, B, C. G. Groth, Lars Bäckman, et al.. (2003). Bicêtre hospital experience with sirolimus-based therapy in human renal transplantation: the sirolimus European renal transplant study. Transplantation Proceedings. 35(3). S58–S61. 24 indexed citations

Foss, A., Gunnar Tufveson, Lars Wennberg, et al.. (2001). Procurement of human pancreases for islet isolation—the initiation of a Scandianvian collaborative network. Transplantation Proceedings. 33(4). 2538–2538. 16 indexed citations

Kobayashi, Takaaki, Atsushi Suzuki, Itsuo Yokoyama, et al.. (2000). Immunogenicity of Hanganutziu-Deicher antigens in pig-to-human xenotransplantation. Transplantation Proceedings. 32(5). 874–874. 5 indexed citations

Wijkstrom, Martin, et al.. (2000). Efficacy of malononitriloamide 279 and 715 in islet xenotransplantation: a study in the pig-to-rat model. Transplantation Proceedings. 32(5). 1024–1024. 2 indexed citations

Bennet, William, Berit Sundberg, Graciela Elgue, et al.. (2000). Complement regulatory proteins on human and porcine nontransgenic and hDAF transgenic islet cells: expression and role in susceptibility to lysis by human serum. Transplantation Proceedings. 32(5). 1066–1066. 2 indexed citations

Behrend, Matthias, Josep M. Grinyó, Yves Vanrenterghem, et al.. (1999). Mycophenolate mofetil in renal transplantation: 3-year results from the placebo-controlled trial. Transplantation. 68(3). 391–396. 173 indexed citations

Takai, Kimio, Akihiko Aoki, Akinobu Suga, et al.. (1998). Urinary tract infections following renal transplantation. Transplantation Proceedings. 30(7). 3140–3141. 46 indexed citations

Groth, C. G., Olle Korsgren, Lars Wennberg, et al.. (1998). Pig-to-human islet transplantation. Transplantation Proceedings. 30(7). 3809–3810. 11 indexed citations

Pichlmayr, R., M. Winkler, P. Neuhaus, et al.. (1997). Three-year follow-up of the European multicenter tacrolimus (FK506) liver study. Transplantation Proceedings. 29(5). 2499–2502. 42 indexed citations

10.

Wennberg, Lars, Alex Karlsson‐Parra, Berit Sundberg, et al.. (1997). EFFICACY OF IMMUNOSUPPRESSIVE DRUGS IN ISLET XENOTRANSPLANTATION. Transplantation. 63(9). 1234–1242. 35 indexed citations

11.

Duraj, Frans, et al.. (1995). Hepatic malignancies, a controversial indication for liver replacement: 10 year experience from a Scandinavian center.. PubMed. 27(6). 3495–6. 1 indexed citations

12.

Devlin, J, R. Williams, P. Neuhaus, et al.. (1994). Renal complications and development of hypertension in the European study of FK 506 and cyclosporin in primary liver transplant recipients. Transplant International. 7(s1). 22–26. 20 indexed citations

13.

Devlin, J, Philip Wong, Roger Williams, et al.. (1994). FK 506 primary immunosuppression following emergency liver transplantation for fulminant hepatic failure. Transplant International. 7(s1). 64–69. 4 indexed citations

14.

Neuhaus, P., P McMaster, R. Y. Calne, et al.. (1994). Neurological complications in the European multicentre study of FK 506 and cyclosporin in primary liver transplantation. Transplant International. 7(s1). 27–31. 32 indexed citations

15.

Korsgren, Olle, et al.. (1993). 15‐Deoxyspergualin Prolongs Pancreatic Islet Allo‐ and Xenograft Survival in Mice. Pharmacology & Toxicology. 73(1). 24–28. 8 indexed citations

16.

Bolinder, Jan, et al.. (1991). Long-term metabolic control after pancreas transplantation with enteric exocrine diversion. Diabetologia. 34(S1). S76–S80. 10 indexed citations

17.

Solders, Göran, et al.. (1991). Improvement in diabetic neuropathy 4 years after successful pancreatic and renal transplantation. Diabetologia. 34(S1). S125–S127. 23 indexed citations

18.

Flatmark, A, H Brynger, & C. G. Groth. (1990). Kidney transplants from living donors: the neglected opportunity. Transplant International. 3(1). 50–51. 2 indexed citations

19.

Strandell, Eva, Arne Andersson, C. G. Groth, & S. Sandler. (1989). Effects of (‐)15‐Deoxyspergualin on Pancreatic Islet B‐Cell Function in Vitro and on the Development of Diabetes after Multiple Low Dose Streptozotocin Administration. Pharmacology & Toxicology. 65(2). 114–118. 10 indexed citations

20.

Groth, C. G., Sten Dreborg, P.A. Öckerman, et al.. (1971). SPLENIC TRANSPLANTATION IN A CASE OF GAUCHER'S DISEASE. The Lancet. 297(7712). 1260–1264. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact